✦ LIBER ✦

76 Adjuvant four cycles of epirubicin and cyclophosphamide with radiation therapy in operated stage II–III breast cancer

✍ Scribed by M. Ünsal; A. Yöney; F. Erman

Book ID: 116166832
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 144 KB
Volume: 31
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(95)95328-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I/II Trial of Adjuvant Dose-Dense

Phase I/II Trial of Adjuvant Dose-Dense Docetaxel/Epirubicin/Cyclophosphamide (TEC) in Stage II and III Breast Cancer

✍ Susan Burdette-Radoux; Marie E. Wood; Julie J. Olin; Rebecca S. Laughlin; Abigai 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 463 KB

Phase I trial of adjuvant chemotherapy w

Phase I trial of adjuvant chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil (CEF) for stage II breast cancer

✍ Stephen E. Jones; Robert G. Mennel; George N. Peters; Mary Alice Westrick; Barry 📂 Article 📅 1988 🏛 Springer US 🌐 English ⚖ 263 KB

Epirubicin is a new anthracycline with a potentially more favorable toxicity profile than the parent compound, doxorubicin. Accordingly, the feasibility and toxicity of 6 courses of adjuvant chemotherapy with cyclophosphamide (C), epirubicin (E), and 5-fluorouracil (F) were assessed in 10 patients w

Adjuvant Therapy of Breast Cancer with P

Adjuvant Therapy of Breast Cancer with Pirarubicin Versus Epirubicin in Combination with Cyclophosphamide and 5-fluorouracil

✍ Jun-Jie Li; Gen-Hong Di; Li-Chen Tang; Ke-Da Yu; Zhen Hu; Guang-Yu Liu; Jing-Son 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

Epirubicin plus cyclophosphamide vs. wee

Epirubicin plus cyclophosphamide vs. weekly paclitaxel as primary systemic therapy in patients with stage II and III breast cancer: randomized phase II study

✍ M. Miyashita; Kohno; S. Takao; K. Wakita; M. Konishi; H. Yoshimura; M. Kubota; Y 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 136 KB

3–39 Prospective Evaluation of Concurren

3–39 Prospective Evaluation of Concurrent Paclitaxel and Radiation Therapy After Adjuvant Doxorubicin and Cyclophosphamide Chemotherapy for Stage II or III Breast Cancer

✍ Yu, T-K; Buchholz, T.A. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Rationale and Design of a Phase III Tria

Rationale and Design of a Phase III Trial of Adjuvant Sequential Epirubicin/Cyclophosphamide and Taxane Versus Concurrent Epirubicin/Taxane in Operable Node-Positive Breast Cancer

✍ Edith A. Perez 📂 Article 📅 2000 🏛 CIG Media Group, LP. 🌐 English ⚖ 116 KB